Researcher profile · Semantic Scholar

A. Boam

h-index: 9
Works: 18
Citations: 6,055

Most-cited papers

Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions
D. Cutlip, S. Windecker, R. Mehran, A. Boam +11 more
2007Circulation5,503 citations
Semantic Scholar
Stent thrombosis redux--the FDA perspective.
A. Farb, A. Boam
2007New England Journal of Medicine301 citations
Semantic Scholar
An Audit of Pharmaceutical Continuous Manufacturing Regulatory Submissions and Outcomes in the US.
Adam C. Fisher, William Liu, Andreas Schick, M. Ramanadham +7 more
2022International journal of pharmaceutics53 citations Open access
Semantic Scholar
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.
J. Daemen, M. Simoons, W. Wijns, A. Bagust +84 more
2008European Heart Journal48 citations Open access
Semantic Scholar
The academic research consortium governance charter.
M. Krucoff, R. Mehran, G. van Es, A. Boam +1 more
2011JACC: Cardiovascular Interventions43 citations Open access
Semantic Scholar
Advancing Product Quality: a Summary of the Second FDA/PQRI Conference
Lawrence X. Yu, I. Akseli, Barbara Allen, G. Amidon +47 more
2016AAPS Journal32 citations Open access
Semantic Scholar
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference
Lawrence X. Yu, Jeffrey C. Baker, S. Berlam, A. Boam +29 more
2015AAPS Journal18 citations Open access
Semantic Scholar
Coronary drug-eluting stent development: issues in trial design.
Neal I. Muni, R. Califf, Jonette R Foy, A. Boam +2 more
2005American Heart Journal16 citations
Semantic Scholar
Drug-eluting stents "deliver heartburn": how do we spell relief going forward?
M. Krucoff, A. Boam, Daniel G. Schultz
2007Circulation14 citations Open access
Semantic Scholar
Regulatory issues facing the development of drug-eluting stents: a US FDA perspective
A. Boam
2006Expert Review of Medical Devices9 citations
Semantic Scholar
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007.
J. Daemen, M. Simoons, W. Wijns, A. Bagust +53 more
2009EuroIntervention8 citations Open access
Semantic Scholar
Challenges in regulating breakthrough medical devices.
Neal I. Muni, T. Gross, A. Boam, Stanley Wang +1 more
2005Food and drug law journal6 citations
Semantic Scholar
Percutaneous Coronary Intervention in Perspective: Drug-Eluting Stents as a Model for Regulatory Review
D. Kandzari, A. Farb, A. Boam
2009Circulation. Cardiovascular Interventions5 citations Open access
Semantic Scholar
Retrospective evaluation of intraocular lenses in adults younger than 60 years
A. Boam, Malvina B. Eydelman, F. Lum, Phyllis M Silverman +3 more
2003Journal of cataract and refractive surgery2 citations
Semantic Scholar
Advancing Product Quality: a Summary of the Second FDA/PQRI Conference
Lawrence X. Yu, I. Akseli, Barbara Allen, G. Amidon +47 more
2016AAPS Journal0 citations Open access
Semantic Scholar
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference
Lawrence X. Yu, J. Baker, S. Berlam, A. Boam +29 more
2015AAPS Journal0 citations Open access
Semantic Scholar
Meeting Report ESC Forum on Drug Eluting Stents European Heart House, Nice, 27 – 28 2007
J. Daemen, M. Simoons, W. Wijns, A. Bagust +83 more
20090 citations
Semantic Scholar
Meeting Report ESC Forum on Drug Eluting Stents European Heart House, Nice, 27 – 28 2007
J. Daemen, M. Simoons, W. Wijns, A. Bagust +83 more
0 citations
Semantic Scholar

J. Bowen

×7

E. Camenzind×7

C. Dimario×7

A. Gitt×7

H. Hillege×7

S. James×7

P. Jüni×7

S. Kloth×7